MGX
Metagenomi Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$1.475
High
$1.475
Low
$1.475
Volume
0.25M
Company Fundamentals
Trading Stats
Related News
Chardan Capital Maintains Buy on Metagenomi, Lowers Price Target to $12
Chardan Capital analyst Geulah Livshits maintains Metagenomi with a Buy and lowers the price target from $13 to $12.
Wells Fargo Maintains Overweight on Metagenomi, Lowers Price Target to $16
Wells Fargo analyst Yanan Zhu maintains Metagenomi with a Overweight and lowers the price target from $20 to $16.
Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025
- Potential best-in-class extrahepatic in vivo gene editing with all-in-one delivery to the central nervous system (CNS) is a critical milestone for the treatment of neurological disorders - - Advancements demonstrate
Metagenomi to Present at Upcoming Scientific Meetings
EMERYVILLE, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (NASDAQ:MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary gene editing
Related Stocks
EQR
Equity Residential Common Shares of Beneficial Interest
RQI
Cohen & Steers Quality Income Realty Fund Inc Common Shares
GLO
Clough Global Opportunities Fund
EGP
EastGroup Properties Inc.
ECCC
Eagle Point Credit Company Inc. 6.50% Series C Term Preferred Stock due 2031
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.